Edward White
Stock Analyst at HC Wainwright & Co.
(1.91)
# 3,225
Out of 5,113 analysts
359
Total ratings
32.31%
Success rate
-6.72%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $12.34 | +167.42% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $9.63 | +76.53% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $4.76 | +215.13% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $4.28 | +40.19% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $0.95 | +1,584.21% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.69 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $9.94 | +704.83% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $4.82 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $4.85 | +312.37% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $7.09 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.67 | +335.97% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $5.66 | +341.70% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.97 | +727.56% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $16.06 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $8.54 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $30.80 | +78.57% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $21.31 | +139.32% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $6.57 | +6.54% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $7.05 | +694.33% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $15.48 | +100.26% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.33 | +403.39% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.95 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $34.74 | -13.64% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.31 | +816.03% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $12.34
Upside: +167.42%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $9.63
Upside: +76.53%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $4.76
Upside: +215.13%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $4.28
Upside: +40.19%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $0.95
Upside: +1,584.21%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.69
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $9.94
Upside: +704.83%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.82
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $4.85
Upside: +312.37%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.09
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.67
Upside: +335.97%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.66
Upside: +341.70%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $0.97
Upside: +727.56%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $16.06
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $8.54
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $30.80
Upside: +78.57%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $21.31
Upside: +139.32%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $6.57
Upside: +6.54%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $7.05
Upside: +694.33%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $15.48
Upside: +100.26%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.33
Upside: +403.39%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.95
Upside: -
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $34.74
Upside: -13.64%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.31
Upside: +816.03%